See Item 3.02.

On January 7, 2014, True Drinks Holdings, Inc. (the "Company") received gross proceeds of $350,000 from the sale of 87,500 shares of Series B Convertible Preferred Stock ("Series B Preferred") to certain accredited investors (each an "Investor" and collectively, the "Investors") in connection with the Series B Offering, previously disclosed by the Company in the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 26, 2013. As additional consideration, the Company issued to the Investors five-year warrants (the "Warrants") to purchase an aggregate total of 408,333 shares of the Company's common stock, par value $0.001 per share ("Common Stock") for $0.30 per share. Each Investor submitted to the Company a signed Securities Purchase Agreement and became a signatory to the Registration Rights Agreement, by and between the Company and all Investors participating in the Series B Offering, dated November 25, 2013. Proceeds from the Series B Offering are expected to be used for general working capital purposes.

The shares of Series B Preferred and Warrants were offered and sold in transactions exempt from registration under the Securities Act of 1933, as amended ("Securities Act"), in reliance on Section 4(2) thereof and Rule 506 of Regulation D thereunder. Each of the investors represented that it was an "accredited investor" as defined in Regulation D.